Category Archives: Supply Chain

Barking Up the Wrong Tree: Affordability, Not Cost Growth, Is The Real Policy Challenge

Jeff Goldsmith Posted 5/7/12 on The Health Affairs Blog A recent spate of commentaries on the continuing health spending moderation raise an important policy question:  If the cost curve is well and truly bent, why are we investing so much … Continue reading

Rate this:

Posted in Analytics, Benefits, Consumerism, Health Care Cost, Imaging, Innovation, Policy/Law/Regulation, Politics, Supply Chain | Tagged , , , | Leave a comment

The GOP Budget, Fiscal Responsibility and Part D

Joe Paduda Posted 4/06/12 on Managed Care Matters Rep. Paul Ryan (R WI) and the House Republicans are touting their budget as fiscally responsible and prudent. What Mr Ryan conveniently forgets, or more likely avoids, is this: Eight short years ago he … Continue reading

Rate this:

Posted in Analytics, Benefits, Conflicts of Interest, Health Care Cost, Medical Management, Policy/Law/Regulation, Politics, Quality, Reform, Supply Chain, Tools | Tagged , , | 1 Comment

The Right Rx for Better Health Care: Rise Up to Challenge the Industry’s Lobbying Power

Brian Klepper and Shannon Brownlee Published 3/29/12 in the New York Daily News Obamacare had its days in the Supreme Court this week, and the justices’ decision could have sweeping consequences for the individual mandate provision in the Patient Protection … Continue reading

Rate this:

Posted in Conflicts of Interest, Health Care Cost, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Politics, Quality, Reform, Supply Chain | Tagged , , , , , , , , | 2 Comments

Another Stent Device Biting The Dust

Tom Emerick Posted 3/26/12 on Cracking Health Costs We’re seeing a trend.  The FDA approves a stent without proper testing.  Death and complication rates with the new stent increase, the FDA is force to review it. Remember the controversy over … Continue reading

Rate this:

Posted in Conflicts of Interest, Market Dynamics, Medical Management, Quality, Supply Chain, Tools | Tagged , , , , , | Leave a comment

Superconsumers and Value Mining: Health Care’s Uber-Trends Driving Care, Everywhere

Jane Sarasohn-Kahn There’s a shift in power in health care moving away from providers and suppliers like pharma and medical device companies, toward patients and payers. This is the new health world according to Ernst & Young‘s latest Progressions report called, The … Continue reading

Rate this:

Posted in Analytics, Benefits, Health Care Cost, Innovation, Market Dynamics, Medical Management, Quality, Supply Chain | Tagged , , , | Leave a comment

MedShare – Recycling Medical Supplies for the Good of the World

Patricia Salber Posted 3/06/12 on The Doctor Weighs In This post was inspired by Kathryn Johnson, Western Regional Council Member of  MedShare, a friend, and a most wonderful connector of people. Today, I drove over to San Leandro, California, the … Continue reading

Rate this:

Posted in Health Care Cost, Innovation, Quality, Supply Chain, Tools | Tagged , , | 1 Comment

The Fiction Behind the Cost of New Drugs

Merrill Goozner Published 2/16/12 in The Fiscal Times The drug industry usually defends the high price on drugs – the latest cancer therapies are tipping the scales at $100,000 a year – by pointing to the large sums it spends … Continue reading

Rate this:

Posted in General, Health Care Cost, Market Dynamics, Supply Chain | Tagged , , , | Leave a comment

It’s 2012. Let’s Recap

Tom Emerick Posted 1/02/11 on Cracking Health Costs Let’s hit a few highlights of 2011.  In Cracking Health Costs we described certain…um…scary trends in health care in the US: US spending on health care is lapping our peer countries while our life expectancy … Continue reading

Rate this:

Posted in Analytics, Benefits, Consumerism, Innovation, Market Dynamics, Medical Management, Physicians, Policy/Law/Regulation, Quality, Reform, Supply Chain | Tagged , , , | 1 Comment

The Latest Advisory Committee at FDA

Merrill Goozner Posted 12/7/11 on Gooz News Is the Food and Drug Administration stacking the deck against a negative decision at tomorrow’s safety hearing for oral contraceptives that contain drospirenone, include Bayer’s Yasmin? Or is it laying the groundwork to … Continue reading

Rate this:

Posted in Innovation, Market Dynamics, Medical Management, Policy/Law/Regulation, Quality, Supply Chain, Tools | Tagged , , | Leave a comment

Ending Pay-For-Delay Deals Could Raise over $5 Billion

Merrill Goozner Posted 11/08/11 on Gooz News The deficit reduction “super committee” charged with coming up with $1.2 trillion in budget reductions over the next decade shouldn’t let this one pass. The Congressional Budget Office today estimated that ending drug industry “pay … Continue reading

Rate this:

Posted in Market Dynamics, Policy/Law/Regulation, Reform, Supply Chain | Tagged , , , , , , | Leave a comment

Buck for the Bang: Premium Med-Tech Pricing

Adi Renbaum Posted 10/31/11 on Medical Device Daily. Cook Medical’s Zilver PTX is likely to become the first peripheral drug-eluting stent (DES) to be approved in the U.S., after an FDA advisory panel voted unanimously in favor of the device on … Continue reading

Rate this:

Posted in Analytics, Innovation, Life Sciences, Market Dynamics, Policy/Law/Regulation, Quality, Supply Chain, Tools | Tagged , , , | Leave a comment

What Happens in Atlantic City…Gets Reported Here

Paul Levy Posted 10/13/11 on Not Running a Hospital  I just returned from giving a keynote address at the Annual Institute of the New Jersey and Metropolitan Philadelphia Chapters of the Healthcare Financial Management Association.  Regular readers of this blog … Continue reading

Rate this:

Posted in Innovation, Market Dynamics, Medical Management, Supply Chain, Tools | Tagged , | Leave a comment

The Great Finesse in Health Reform- Changing The Language

Richard Reece Posted 10/13/11 on MedInnovations Blog One man’s words are another man’s poison. Anonymous We were reasonably calculating in our approach. We consciously began using the language of the marketplace, rather than the language of medicine. We began talking … Continue reading

Rate this:

Posted in Market Dynamics, Medical Management, Physicians, Quality, Reform, Supply Chain | Tagged , , , | 1 Comment

Less is More: Top-Performing Hospitals Spend Less on Pharmacy and Supplies

Jane Sarasohn-Kahn First posted 9/11/11 on Health Populi The Top 100 performing hospitals in the U.S. spend 13% less on supply costs and 6% less on pharmacy costs, according to a research brief fromThomson Reuters, Associations Between Supply and Pharmacy Service Intensity, System … Continue reading

Rate this:

Posted in Analytics, Market Dynamics, Medical Management, Quality, Supply Chain | Tagged , , , | 1 Comment

U.S. Hospitals Face Gloomiest Economic Outlook in 20 Years

Jane Sarasohn-Kahn First posted 9/08/11 on Health Populi Revenues = volume x price. This is the financial reality for every organization that makes its money serving customers, whether for-profit or not-for-profit. For the U.S. hospital sector, both volumes and prices are falling, leading … Continue reading

Rate this:

Posted in Analytics, Market Dynamics, Supply Chain | Tagged , , , | Leave a comment